Selective pacing algorithms for prevention of atrial fibrillation: The final chapter?

Heart Rhythm

Volumn 6, Issue 3, 2009, Pages 302-304

  Gillis, Anne M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTIFICIAL HEART PACEMAKER; CLINICAL PRACTICE; CLINICAL TRIAL; EDITORIAL; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART VENTRICLE PACING; HUMAN; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; THERAPY EFFECT;

ALGORITHMS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; HUMANS; PACEMAKER, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 60749083835     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.01.011     Document Type: Editorial

References (24)

1. Gillis A.M. Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol 10 Suppl 1 (2004) 55-62
2. Ellenbogen K.A. Pacing therapy for prevention of atrial fibrillation. Heart Rhythm 4 3 Suppl (2007) S84-S87
3. Garrigue S., Barold S.S., Cazeau S., et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol 21 (1998) 1751-1759
4. Gillis A.M., Wyse D.G., Connolly S.J., et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 99 (1999) 2553-2558
5. Lee M.A., Weachter R., Pollak S., et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 41 (2003) 1926-1932
6. Padeletti L., Pürerfellner H., Adler S.W., et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 14 (2003) 1189-1195
7. Carlson M.D., Ip J., Messenger J., et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42 (2003) 627-633
8. de Voogt W., van Hemel N., de Vusser P., et al. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation. Europace 9 (2007) 798-804
9. Camm A.J., Sulke N., Edvardsson N., et al. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AF Therapy study. Europace 9 (2007) 1107-1109
10. Blanc J.J., De Roy L., Mansourati J., et al. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 6 (2004) 371-379
11. Pürerfellner H., Ruiter J.H., Widdershoven J.W., et al. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm. Heart Rhythm 3 (2006) 1164-1171
12. Lewalter T., Yang A., Pfeiffer D., et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin Electrophysiol 29 (2006) 124-134
13. Mont L., Ruiz-Granell R., Martínez J.G., et al. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the Prevention Or Termination (POT) trial. Europace 10 (2008) 28-34
14. Sweeney M.O., Bank A.J., Nsah E., et al. Search AV extension and managed ventricular pacing for promoting atrioventricular conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 357 (2007) 1000-1008
15. Gillis A.M., Pürerfellner H., Israel C.W., et al. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol 29 (2006) 697-705
16. Gold M.R., Hoffmann E., and SAFARI Investigators. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI). Am Heart J 152 (2006) 231-236
17. Gold M.R., Adler S., Fauchier L., et al. The impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study for Atrial Fibrillation Reduction (SAFARI) Trial. Heart Rhythm 6 (2009) 295-301
18. Warman E.N., Grammatico A., and Padeletti L. Sample size estimates for atrial fibrillation endpoints. Heart Rhythm 1 2 Suppl (2004 Jul) B58-B62
19. Gillis A.M. Rhythm control in atrial fibrillation: endpoints for device-based trials. Heart Rhythm 1 2 Suppl (2004) B52-B57
20. Gillis A.M., Koehler J., Morck M., et al. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm 2 (2005) 791-796
21. Gillis A.M., Morck M., Exner D.V., et al. Impact of atrial antitachycardia pacing therapy and atrial pace prevention therapies on atrial fibrillation burden over long term follow-up. Heart Rhythm 4 (2007) S211
22. Purerfellner H., Gillis A.M., Holbrook R., et al. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol 27 (2004) 983-992
23. Nielsen J.C., Kristensen L., Andersen H.R., et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 42 (2003) 614-623
24. Willems R., Wyse D.G., Gillis A.M., and Atrial Pacing Periablation for Paroxysmal Atrial Fibrillation (PA3) Study Investigators. Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 14 (2003) 1296-1301